A Multicentered, Double - Blind, Randomized, and Placebo - Controlled Clinical Trial With Inactivated Enterovirus Type 71 (EV71) Vaccines.
Phase of Trial: Phase III
Latest Information Update: 14 May 2015
At a glance
- Drugs Enterovirus A vaccine (Primary)
- Indications Coxsackievirus infections; Enterovirus A infections
- Focus Registrational; Therapeutic Use
- Sponsors Sinovac Biotech
- 14 May 2015 Data from this trial supported the filing of a new drug application with the China Food & Drug Administration, and batch testing is being conducted, according to a Sinovac Biotech media release.
- 27 Feb 2014 Results published in the New England Journal of Medicine.
- 26 Feb 2014 Results have been published in The New England Journal of Medicine according to a Sinovac media release. Results were also summarised in the media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History